RBC Units and Hemolysis: The Quality Indicator that Says it All
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, posted on LinkedIn:
”RBC Units and Hemolysis: the quality indicator that says it all
Red Blood Cell (RBC) concentrates are among the most sensitive blood components. Their integrity is shaped at every step of the transfusion chain – and hemolysis remains the most telling indicator of overall product quality.
International guidelines are clear:
• ≤ 0.8 % hemolysis at end of storage (European standards)
• ≤ 1 5according to AABB guidelines
These thresholds highlight the importance of protecting the erythrocyte membrane from cumulative stress.
1. Mechanical factors
Red cells are highly sensitive to physical stress:
• Too fast transfer of the RBC concentrate through the break-away cannula
• Kinking of the tubing during component separation
• Overly aggressive or poorly calibrated centrifugation
• Wrong sampling procedure
Such mechanical stresses create micro-lesions that can significantly increase hemolysis during storage.
2. Thermal factors
Thermal control is critical:
• Storage temperature too low
• Repeated fluctuations in the cold chain
• Thermal shock during collection or environmental transitions
Rapid variations weaken membrane stability and increase permeability.
3. Storage-related factors
Over time, several changes accumulate:
• Insufficient mixing with anticoagulant during collection
• Medium acidification
• Increased oxidative stress
• Reduced ATP levels, essential for membrane flexibility and resilience
Controlling hemolysis means protecting the RBC unit at every moment. A small percentage… that speaks volumes about quality.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin